Privacy protected and anonymized by ShouldEye. No AI training. Learn more
AI Trust Score, Reviews & Company Verification
Is this your company? Claim the BioNTech SE profile to verify ownership and manage company-provided details.
Independent company assessment
9.1/10A · Exceptional
24 indexed evidence signals reviewed
AI Comparison
Mixed Consensus70% Confidence
Based on 5 polled AI models
- GeminiGoogle DeepMindSafe80%Confidence
- GrokxAIMixed72%Confidence
- DeepSeekDeepSeekMixed65%Confidence
- GLMZ.aiMixed68%Confidence
Key stats
- Sector
- Biotechnology Companies
- Headquarters
- US
- Domain
- biontech.com
- Domain history
- Not available
- Risk tier
- Low
- Assessed
- Aug 27, 2026
BioNTech SE hasn't claimed this profile yet
ShouldEye AI builds this page from public sources. Nothing here is approved by BioNTech SE.
- Reply to reviews
- Publish your brand message
- Earn the trust seal
Claiming gives you a voice, not control of the trust score.
Free for verified company teams
BioNTech SE is a German multinational biotechnology company that develops mRNA-based cancer immunotherapies, targeted therapies, and vaccines against infectious diseases.
- Headquarters
- US
Full intelligence report for BioNTech SE
BioNTech demonstrates strong institutional discipline across compliance and consumer protection, with exceptional regulatory standing, robust legal frameworks, and largely positive user sentiment reflecting rigorous pharmaceutical-sector oversight. Slightly more modest scores in domain integrity, customer service, and reputation suggest room for improvement in digital presence and direct consumer engagement, though the broadly elevated profile indicates a verified, transparent operation that prioritizes accountability.
- Provides a comprehensive, categorized cookie disclosure with clear purposes, vendors, durations, and domains
- Implements an opt‑in consent model for non‑essential cookies and offers granular user settings
- Demonstrates strong regulatory compliance: no enforcement actions identified, proactive compliance programs, Sarbanes‑Oxley certifications, and transparent public disclosures of legal matters
- Engages in cross‑site tracking and collection of device characteristics that enable browser fingerprinting, and shares data with third‑party advertising networks (e.g., Google)
- Collects approximate location data based on IP address without explicit consent and uses broad legitimate‑interest justifications for processing
- Privacy policy lacks specific data‑retention periods for several activities and implies consent for certain processing (e.g., surveys, tax refunds)
Connect with BioNTech SE
Find us across the web
Links found on the company website.
Public-facing leadership and ownership signals for BioNTech SE — synthesized from verified profiles and corporate disclosures where available.